Singapore, 5 June 2014 /PRNewswire/ — QT Vascular Ltd. (QT Vascular) is pleased to announce that on
4 June 2014, its wholly owned US subsidiary, TriReme Medical LLC, received notification from the
United States Food and Drug Administration (FDA) of 510(K) clearance to market the Chocolate® PTCA
Balloon Catheter (Chocolate PTCA) in the United States, for balloon dilatation of the stenotic portion of
coronary artery or bypass graft stenosis for the purpose of improving myocardial perfusion.

Singapore, 26 May 2014 – MerLion Pharmaceuticals (MerLion) announced today that its
North American partner has achieved a significant regulatory milestone in the development of
finafloxacin for the treatment of acute otitis external (bacterial infection of the outer ear).

SINGAPORE, May 6, 2014 /PRNewswire/ — QT Vascular Ltd. (QT Vascular) is pleased to announce that it has started
clinical cases with the Chocolate® PTA balloon catheter (Chocolate® PTA) in Singapore. Five cases were performed at
National University Hospital (NUH) and Changi General Hospital (CGH).

SINGAPORE, March 27, 2014 — TriReme Medical LLC, a subsidiary of Singapore-based QT
Vascular Ltd. announced today that three patients have been enrolled in a clinical study of
its unique drug-coated Chocolate® PTA balloon. Dr. Andrew Holden, co-Principal
Investigator of the study, performed these procedures at Auckland City Hospital, in
Auckland, New Zealand.

March 12, 2014 – PatientSafe Solutions, a leader in smart point-of-care mobile
solutions for healthcare, today announced a new strategic investment of $3
million from TELUS Ventures. The investment will power the adoption of
PatientSafe’s clinical workflow solution, the PatientTouch®
system, an intuitive
mobile platform allowing caregivers to easily communicate and collaborate with
each other from the patient’s side

Solution delivers tight integration between RAMP’s next-generation video experience
and MAX451’s business-transformation platform for Microsoft Office 365,
Cloud9MAX

PLEASANTON Calif. and SINGAPORE, February 19, 2014 /PRNewswire/ — TriReme
Medical LLC, a subsidiary of Singapore based QT Vascular Ltd., announced today that it has
signed a broad distribution agreement with Cordis Corporation for the exclusive distribution of
its unique Chocolate® PTA Balloon Angioplasty Catheter, with an option for additional
TriReme portfolio products. This agreement will expand TriReme’s commercial footprint and
allow the company to focus on its promising development pipeline.

Escondido, Calif. – Meghan Jaremczuk’s life just got a lot easier, and the care she offers her patients a little safer.

Integration of RAMP’s next-generation video and search technology with Polycom® RealPresence® Media
Manager brings enhanced media search and interactive user experiences to videoconferencing

PLEASANTON Calif. and SINGAPORE, February 6, 2014 /PRNewswire/ — Interim results from The CHOCOLATE®
BAR Registry conducted in the US demonstrate that use of the Chocolate® PTA balloon achieved high rates of
treatment success and limb preservation in patients with peripheral arterial disease. The results from the first
350 patients enrolled and treated were presented by Dr. Tony Das (Cardiovascular Research Institute, Dallas, TX)
at the Leipzig Interventional Course, LINC 2014.